Schonfeld Strategic Advisors »

Kymera Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.2M 40k 56.60
2025-06-30 $2.6M 59k 43.64
2025-03-31 $1.3M 48k 27.37
2024-12-31 $8.7M 216k 40.23
2024-09-30 $8.5M 179k 47.33
2024-06-30 $8.6M 290k 29.85
2024-03-31 $15M 380k 40.20
2023-12-31 $11M 438k 25.46
2022-12-31 $434k 17k 24.96
2020-09-30 $216k 6.7k 32.37